US Stock MarketDetailed Quotes

NRXS Neuraxis

Watchlist
  • 2.180
  • +0.070+3.32%
Close Feb 28 16:00 ET
15.64MMarket Cap-1.80P/E (TTM)
Full Hours
  • 5D
  • Daily
  • Weekly
  • Monthly
  • 1Q
  • 1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Comments

    Jaguar8
    Jaguar8
    Jan 21 12:46
    NEWS
    $Neuraxis (NRXS.US)$
    UPDATE - NeurAxis Announces New Medical Policy Coverage with a Prominent Insurer for Over Five Million Lives Across Multiple States
    Tuesday, 21st January at 1:45 pm
    CARMEL, Ind., Jan. 21, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, today announced medical policy coverage for Percutaneous Elec...
    Jaguar8
    Jaguar8
    Jan 21 08:14
    NEWS
    $Neuraxis (NRXS.US)$
    01/21/2025 - 06:00 AM
    CARMEL, Ind., Jan. 21, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, today announced medical policy coverage for Percutaneous Electrical Nerve Field Stimulation (PENFS), with Molina Healthcare. Molina, with over 40 years in operation, has approximately 5.1 million...
    Trytosaveabit
    Trytosaveabit
    Jan 21 08:11
    news
    $Neuraxis (NRXS.US)$ NeurAxis Announces Molina Healthcare Coverage For PENFS Therapy IB-Stim, FDA-Cleared For Treating Abdominal Pain In IBS Adolescents
    Benzinga· 4 mins ago
    1
    Jaguar8
    Jaguar8
    Dec 10, 2024 08:01
    NEWS
    $Neuraxis (NRXS.US)$
    NeurAxis Inc. Announces FDA 510(k) Clearance of RED for Testing and Evaluation of Patients with Chronic Constipation
    Tuesday, 10th December at 9:00 am
    RED has been designed to duplicate test performance of traditional balloon expulsion test (BET) and manual sensation testing devices without needing electronics or software.
    NeurAxis Inc. will begin the process of commercially marketing RED and expects initial revenues in 1Q25 as there is a Category I CPT code assigned to t...
    Trytosaveabit
    Trytosaveabit
    Nov 4, 2024 08:04
    News
    $Neuraxis (NRXS.US)$ NeurAxis Receives New FDA 510(K) Clearance for IB-Stim, Expanding its Addressable Market
    3 MINUTES AGO, 9:00 AM EST
    VIA GLOBENEWSWIRE
Read more

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
LINTEX
920106
+30.00%
LINGOOD
833284
+29.98%
NTGEC
870436
+29.98%
4
CG MED EQUIP.
838810
+29.97%
5
Jiayu Holding
300117
+20.48%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Monetary Policy: Navigating the Fed's Rate Cut Cycle
Changing Fed policy is altering the market math for investors.
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More
TSLA earnings preview: Grab rewards by guessing the opening price!